Helicobacter pylori-associated peptic ulcer disease: A retrospective analysis of post-treatment testing practices

Helicobacter PyloriInflammatory Bowel Disease

Factors Associated With Adherence to Helicobacter pylori Testing During Hospitalization for Bleeding Peptic Ulcer Disease

Clin Gastroenterol Hepatol.

Hung KW, Knotts RM, Faye AS, Pont AR, Lebwohl B, Abrams JA, Freedberg DE

doi: 10.1016/j.cgh.2019.07.037.

Helicobacter Pylori

Helicobacter pylori increases the risk of low-dose aspirin ulcers: A meta-analysis

J Gastroenterol Hepatol.

Sarri GL, Grigg SE, Yeomans ND

doi: 10.1111/jgh.14539.

Inflammatory Bowel Disease

Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors

Aliment Pharmacol Ther.

Venerito M, Schneider C, Costanzo R, Breja R, Röhl FW, Malfertheiner P

doi: 10.1111/apt.14652.

Gastrointestinal DiseasesInflammatory Bowel Disease

Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials

Lancet Gastroenterol Hepatol.

Scally B, Emberson JR, Spata E, Reith C, Davies K, Halls H, Holland L, Wilson K, Bhala N, Hawkey C, Hochberg M, Hunt R, Laine L, Lanas A, Patrono C, Baigent C

doi: 10.1016/S2468-1253

Esophagus DiseasesHelicobacter Pylori

Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis-a Systematic Review and Meta-analysis

Clin Gastroenterol Hepatol.

Shah SC, Tepler A, Peek RM Jr, Colombel JF, Hirano I, Narula N

doi: 10.1016/j.cgh.2019.01.013.

Helicobacter Pylori

Clostridium difficile-associated disease and Helicobacter pylori seroprevalence: A case-control study

Helicobacter.

Muhsen K, Na'amnih W, Adler A, Carmeli Y, Cohen D

doi: 10.1111/hel.12668.

Helicobacter Pylori

Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection

Am J Gastroenterol.

Kumar S, Metz DC, Kaplan DE, Goldberg DS

doi: 10.14309/ajg.0000000000000626.

Inflammatory Bowel Disease

Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study

Inflamm Bowel Dis.

Reinisch W, Panaccione R, Bossuyt P, Baert F, Armuzzi A, Hébuterne X, Travis S, Danese S, Sandborn WJ, Schreiber S, Berg S, Zhou Q, Kligys K, Neimark E, Suleiman AA, D'Haens G, Colombel JF

doi: 10.1093/ibd/izaa025.

RECOMMENDED

Helicobacter Pylori

Review: Helicobacter pylori and non-malignant upper gastrointestinal diseases

Helicobacter.

Boltin D, Niv Y, Schütte K, Schulz C

doi: 10.1111/hel.12637.

Related content

Factors Associated With Adherence to Helicobacter pylori Testing During Hospitalization for Bleeding Peptic Ulcer Disease

Helicobacter pylori increases the risk of low-dose aspirin ulcers: A meta-analysis

Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors

Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials

Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis-a Systematic Review and Meta-analysis

Clostridium difficile-associated disease and Helicobacter pylori seroprevalence: A case-control study

Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection

Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study

Review: Helicobacter pylori and non-malignant upper gastrointestinal diseases